NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required)
About
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required) is a federal funding opportunity from National Institutes of Health. This forecasted grant opportunity (FOR-OD-26-004) is available nationwide for eligible applicants.
The NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required) is a federal funding opportunity designed for small businesses and research institutions collaborating to develop innovative technologies with commercial potential in the biomedical and health sciences fields. This grant program specifically supports projects that include clinical trial components, making it ideal for entrepreneurs and small business owners working on breakthrough medical devices, therapeutics, diagnostics, or healthcare solutions. The STTR program fosters partnerships between small businesses and research institutions to bridge the gap between basic research and commercialization. Small business applicants should consider applying if they have promising technology that requires clinical validation and are seeking federal investment to advance their innovation from concept through proof-of-concept and into commercial development. The R41/R42 phase structure allows businesses to conduct preliminary studies before committing to larger-scale clinical trials. This grant is particularly valuable for entrepreneurs in the life sciences and healthcare sectors who need substantial resources and credibility to accelerate their product development timeline and market entry strategy.
Grant Details
Funding Range
Varies by phase and cycle
Grant Type
Federal
Application Cycle
Annual (verify current cycle on NIH website)
Best For
Small businesses partnering with research institutions developing healthcare technologies and biomedical innovations
Frequently Asked Questions
Who is eligible for NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required)?
Eligibility requirements for STTR grants typically include small businesses (meeting SBA size standards) partnering with research institutions. However, specific eligibility criteria for this forecasted grant opportunity (FOR-OD-26-004) should be verified on the official NIH STTR website, as requirements may vary by funding cycle and research focus areas.
How much funding does NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required) provide?
The specific funding amounts vary by grant phase and research focus area. For detailed information about award amounts for R41 and R42 phases, applicants should consult the official NIH STTR program announcement and the most current funding opportunity details on grants.nih.gov.
How do I apply for NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required)?
Applications for NIH STTR grants are typically submitted through Grants.gov using the NIH SF424 application form. The process involves preparing a detailed project proposal, budget, and supporting documentation. For specific application instructions, deadlines, and submission requirements for this forecasted opportunity, visit the official NIH STTR program page and the associated funding opportunity announcement (FOR-OD-26-004).
What can NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Required) funding be used for?
STTR funding supports research and development activities that advance promising technologies toward commercialization. Given the clinical trial requirement, funds may be used for feasibility studies, preliminary clinical trials, technology development, and activities that establish the commercial potential of the innovation. Consult the official funding announcement for comprehensive guidance on allowable uses of funds.
Last updated: March 1, 2026